The article and the video highlights our supervised AI-driven platform, developed by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, which enhances the precision of Deep Brain Stimulation (DBS). This innovative approach promises to make neurosurgical procedures safer and more effective for patients.
We are delighted to share that MedTech Strategist has featured RebrAIn in their latest issue.The article explores how our supervised AI-driven platform, OptimMRI, simplifies precision targeting for Deep Brain Stimulation (DBS) in Parkinson’s Disease. By enhancing...
We are excited to share that the Focused Ultrasound Foundation has featured RebrAIn for our pioneering use of artificial intelligence in brain targeting. The article details how our supervised AI-driven platform, Optim MRI, enhances precision and effectiveness in...
We are pleased to share that L'Usine Digitale has featured RebrAIn for securing €3.7 million to advance our supervised AI-driven software. This innovative platform is designed to simplify the work of neurosurgeons by enhancing the precision and efficiency of Deep...